Precision’s Snider Interviewed by AJMC Regarding New CAR-T Societal Value Study



A new Precision Health Economics-authored study on the societal value of CAR-T therapy is generating a significant level of interest within the scientific community. PHE’s Julia Snider touches on some of the key takeaways of the study, presented at this year’s ASH, with the American Journal of Managed Care.

To read the complete article including Julia’s comments, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.